MAPT and Alzheimer disease: As the ratio of Aβ42 to T-tau can be artificially increased via increases in T-tau levels only, however, (e.g., due acute brain disorders such as trauma or stroke) it has been recommended that CSF AD biomarkers are to be interpreted as independent measures [9].